Skip to main content

Table 6 Analysis of factors influencing the occurrence of pneumonitis patients with radiochemotherapy in LD-SCLC

From: Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting

Characteristics

Pneumonitis

OR (95% CI)

p

Age

1.0 (0.9–1.1)

0.45

Sex

 Male

Ref.

 Female

0.2 (0.0–1.2)

0.08

Karnofsky

 80–100

Ref.

 < 80

1.3 (0.3–5.6)

0.72

Start during cycle

 Early start

Ref.

 Late start

3.8 (0.7–22.1)

0.14

 Very late start

4.9 (0.6–40.0)

0.14

Mean lung dose

1.2 (0.9–1.6)

0.15

PTV

1.0 (1.0–1.0)

0.44

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us